B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma. (Q53251886)

12 May 2018

title

B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma. (English)

1 reference

12 May 2018

esophageal squamous cell carcinoma

main subject

1 reference

Lu-jun Chen

1

1 reference

12 May 2018

Jing Sun

2

1 reference

12 May 2018

Hong-ya Wu

3

1 reference

12 May 2018

Shu-ming Zhou

4

1 reference

12 May 2018

Yan Tan

5

1 reference

12 May 2018

Ming Tan

6

1 reference

12 May 2018

Bao-en Shan

7

1 reference

12 May 2018

Bin-feng Lu

8

1 reference

12 May 2018

Xue-guang Zhang

9

1 reference

12 May 2018

publication date

26 April 2011

1 reference

12 May 2018

Cancer Immunology, Immunotherapy

published in

1 reference

12 May 2018

volume

60

1 reference

12 May 2018

issue

7

1 reference

12 May 2018

page(s)

1047-1055

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1007/s00262-011-1017-3

exact match

0 references

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

Chemoprevention of esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

Immunolocalisation of tissue factor in esophageal cancer is correlated with intratumoral angiogenesis and prognosis of the patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

Treatment outcomes of resected esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

Etiology and chemoprevention of esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

CD28/B7 costimulation: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

Inhibitory B7-family molecules in the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

B7-H4, a molecule of the B7 family, negatively regulates T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

B7-H4 overexpression in ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

B7-H3 and B7-H4 expression in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

B7-h4 is highly expressed in ductal and lobular breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

B7-H4 reverse signaling induces the apoptosis of EBV-transformed B cells through Fas ligand up-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

A novel transcription factor, T-bet, directs Th1 lineage commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

T-bet and eomesodermin are required for T cell-mediated antitumor immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

The host-tumor immune conflict: from immunosuppression to resistance and destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

B7-H4 Is a Novel Membrane-Bound Protein and a Candidate Serum and Tissue Biomarker for Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1017-3

10.1007/S00262-011-1017-3

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

21519829

1 reference

12 May 2018